Parallel Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.67K Sell
269
-1,637
-86% -$35.2K ﹤0.01% 3039
2026
Q1
$21.9K Buy
1,906
+1,712
+882% +$24.1K ﹤0.01% 2435
2025
Q4
$2.79K Sell
194
-440
-69% -$7.61K ﹤0.01% 3038
2025
Q3
$12K Buy
634
+2
+0.3% +$33 ﹤0.01% 2469
2025
Q2
$13.6K Buy
632
+497
+368% +$7.39K ﹤0.01% 2366
2025
Q1
$1.77K Sell
135
-14
-9% -$208 ﹤0.01% 3008
2024
Q4
$2K Sell
149
-2
-1% -$32 ﹤0.01% 2969
2024
Q3
$3.2K Sell
151
-3
-2% -$54 ﹤0.01% 2759
2024
Q2
$2.44K Buy
154
+54
+54% +$992 ﹤0.01% 2757
2024
Q1
$1.49K Hold
100
﹤0.01% 2867
2023
Q4
$915 Buy
100
+65
+186% +$449 ﹤0.01% 2952
2023
Q3
$195 Hold
35
﹤0.01% 3234
2023
Q2
$282 Sell
35
-559
-94% -$4.12K ﹤0.01% 3200
2023
Q1
$3.88K Hold
594
﹤0.01% 2502
2022
Q4
$1.46K Buy
594
+35
+6% +$109 ﹤0.01% 2796
2022
Q3
$3K Hold
559
﹤0.01% 2512
2022
Q2
$2K Buy
+559
New +$3.56K ﹤0.01% 2612

Other funds holding OSCR

Parallel Advisors's OSCR Position: Q2 2026 in Review

Parallel Advisors reduced its Oscar Health (OSCR) stake by 86% in Q2 2026, selling an estimated $35.2K and leaving 269 shares worth $7.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

Parallel Advisors first reported a position in OSCR in Q2 2022 and has held it in 17 quarters since. The position peaked at $21.9K in Q1 2026. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Parallel Advisors held 269 shares of Oscar Health worth $7.67K as of Q2 2026.
  • Parallel Advisors sold 1,637 Oscar Health shares in Q2 2026, an estimated $35.2K.
  • Oscar Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3039 holding.
  • Parallel Advisors first reported a position in Oscar Health in Q2 2022 and has held it in 17 quarters since.
  • Parallel Advisors's Oscar Health position peaked at $21.9K in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.